Search results
Showing 8611 to 8625 of 8973 results
Discontinued Reference number: GID-TA10803
Discontinued Reference number: GID-TA11351
Discontinued Reference number: GID-TA11146
In development Reference number: GID-TA11511 Expected publication date: TBC
In development Reference number: GID-TA10391 Expected publication date: TBC
In development Reference number: GID-TA11808 Expected publication date: TBC
In development Reference number: GID-TA11697 Expected publication date: TBC
In development Reference number: GID-TA11709 Expected publication date: TBC
Iclepertin for treating cognitive impairment associated with schizophrenia [ID6483]
Discontinued Reference number: GID-TA11647
This guidance has been replaced by NICE guideline NG17.
Farco-fill Protect for indwelling urinary catheterisation (MIB121)
July 2021: NICE has withdrawn the medtech innovation briefing (MIB) on Farco-fill Protect for indwelling urinary catheterisation because the product has been withdrawn from the UK market.
Home News Podcasts The asthma guideline – one year on Podcasts 29 January 2026 Listen About this episode Developed collaboratively by the
Major changes to type 2 diabetes treatment could save thousands of lives
New guidance means millions of people will get access to medicines that protect the heart and kidneys, while NHS savings of £560 million from using generic dapagliflozin can be reinvested elsewhere in NHS care.
NICE has retired this cancer service guideline because the recommendations are no longer being kept up to date and may no longer reflect best practice.
Improving supportive and palliative care for adults with cancer (CSG4)
NICE has retired this cancer service guideline because the recommendations are no longer being kept up to date and may no longer reflect best practice.